Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.433
-0.051 (-10.58%)
At close: Jan 31, 2025, 4:00 PM
0.463
+0.030 (6.91%)
After-hours: Jan 31, 2025, 5:54 PM EST
Turnstone Biologics Market Cap
Turnstone Biologics has a market cap or net worth of $10.01 million as of January 31, 2025. Its market cap has decreased by -78.43% in one year.
Market Cap
10.01M
Enterprise Value
-33.58M
1-Year Change
-78.43%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since the IPO on July 21, 2023, Turnstone Biologics's market cap has decreased from $255.86M to $10.01M, a decrease of -96.09%. That is a compound annual growth rate of -87.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2025 | 11.19M | -2.60% |
| Dec 31, 2024 | 11.49M | -80.45% |
| Dec 29, 2023 | 58.77M | -77.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |